Identification of potent small molecule inhibitors of SARS-CoV-2 entry
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of potent small molecule inhibitors of SARS-CoV-2 entry
Authors
Keywords
-
Journal
SLAS Discovery
Volume 27, Issue 1, Pages 8-19
Publisher
Elsevier BV
Online
2022-01-25
DOI
10.1016/j.slasd.2021.10.012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection
- (2021) Jennifer S. Chen et al. JOURNAL OF VIROLOGY
- Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and Influenza virus
- (2021) Einat.B. Vitner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
- (2021) Carmen Elena Gómez et al. Vaccines
- X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
- (2021) Sebastian Günther et al. SCIENCE
- Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion
- (2021) Mohd Zulkifli Salleh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- (2020) Yushun Wan et al. JOURNAL OF VIROLOGY
- Glucosylceramide synthase maintains influenza virus entry and infection
- (2020) Kelly Drews et al. PLoS One
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- Chemistry and Biology of SARS-CoV-2
- (2020) Alexander Dömling et al. Chem
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
- (2020) Yuan Huang et al. ACTA PHARMACOLOGICA SINICA
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Review on the coronavirus disease (COVID‐19) pandemic: its outbreak and current status
- (2020) Dalia Almaghaslah et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
- (2020) Natacha S. Ogando et al. JOURNAL OF GENERAL VIROLOGY
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Remdesivir against COVID-19 and Other Viral Diseases
- (2020) Jakob J. Malin et al. CLINICAL MICROBIOLOGY REVIEWS
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
- (2020) Geoffrey Mark Verrall Frontiers in Immunology
- SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
- (2020) Lizhou Zhang et al. Nature Communications
- Inhibiting extracellular vesicles formation and release: a review of EV inhibitors
- (2019) Mariadelva Catalano et al. Journal of Extracellular Vesicles
- Antitumor Effect of Calcium-Mediated Destabilization of Epithelial Growth Factor Receptor on Non-Small Cell Lung Carcinoma
- (2018) In Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Calpain inhibition attenuates bleomycin-induced pulmonary fibrosis via switching the development of epithelial-mesenchymal transition
- (2018) Yuan Liu et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Calpeptin attenuates cigarette smoke-induced pulmonary inflammation via suppressing calpain/IκBα signaling in mice and BEAS-2B cells
- (2018) Jingjing Zuo et al. PATHOLOGY RESEARCH AND PRACTICE
- Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells
- (2018) Jean Kaoru Millet et al. VIROLOGY
- Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014
- (2018) Wolfgang Froestl et al. JOURNAL OF ALZHEIMERS DISEASE
- Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice
- (2018) Sandra de la Fuente et al. MOLECULAR NEUROBIOLOGY
- The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
- (2018) Jeff Janes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer.
- (2018) Vito W Rebecca et al. Cancer Discovery
- Inhibition of Calpains Protects Mn-Induced Neurotransmitter release disorders in Synaptosomes from Mice: Involvement of SNARE Complex and Synaptic Vesicle Fusion
- (2017) Can Wang et al. Scientific Reports
- Calpain-activated mTORC2/Akt pathway mediates airway smooth muscle remodelling in asthma
- (2016) S.-S. Rao et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Protease inhibitors targeting coronavirus and filovirus entry
- (2015) Yanchen Zhou et al. ANTIVIRAL RESEARCH
- Neuroprotective Effect of Calpeptin on Acrylamide-Induced Neuropathy in Rats
- (2015) Xiaomin Wei et al. NEUROCHEMICAL RESEARCH
- Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors
- (2015) Marton Siklos et al. Acta Pharmaceutica Sinica B
- Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials
- (2013) Chiara Zanetta et al. CLINICAL THERAPEUTICS
- Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain
- (2012) Martha Schneider et al. JOURNAL OF VIROLOGY
- The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice
- (2010) C. Tabata et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The protective effects and potential mechanism of Calpain inhibitor Calpeptin against focal cerebral ischemia–reperfusion injury in rats
- (2010) Sheng Peng et al. MOLECULAR BIOLOGY REPORTS
- Calpain inhibition preserves myocardial structure and function following myocardial infarction
- (2009) Santhosh K. Mani et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cathepsin L Functionally Cleaves the Severe Acute Respiratory Syndrome Coronavirus Class I Fusion Protein Upstream of Rather than Adjacent to the Fusion Peptide
- (2008) B. J. Bosch et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started